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Maastricht, Maastricht, The NetherlandsIntroduction. Accumulating evidence suggests that patients with abdominal aortic aneurysm (AAA) suffer from a systemic
dilating condition affecting all arteries. Matrix metalloproteinases (MMPs) and their natural inhibitors, the tissue inhibitors
of metalloproteinases (TIMPs), appear to be involved in aneurysm formation, as evidenced by increased aortic tissue MMP
activity and plasma MMP levels in patients with AAA. Hypothesizing that an imbalance in plasma MMP/TIMP level
might be associated with a systemic dilation diathesis, we studied mechanical vessel wall properties of non-affected arteries of
patients with either AAA or aorto-iliac obstructive lesions in association with plasma MMP-9 and TIMP-1 levels.
Methods. Twenty-two patients with AAA and 12 with aorto-iliac occlusive disease (AOD) were included. Diastolic
diameter (d) and distension (Dd) were measured at the level of the common carotid artery (CCA) and suprarenal aorta (SA)
using ultrasonography. Distensibility (DC) and compliance (CC) were calculated from d, Dd and brachial pulse pressure.
Plasma MMP-9 and TIMP-1 were determined with specific immunoassays.
Results. The average (GSD) age was 72.3G5.6 and 65.0G8.2 years for the AAA and AOD patients, respectively, (PZ
0.005). CCA diameter was 9.1G1.3 mm in AAA patients and AOD 7.8G1.4 mm in AOD patients, PZ0.009. This
difference persisted after correction for age. PlasmaMMP-9 and TIMP-1 did not differ significantly between AAA and AOD
patients. In the total 34 patients, the MMP-9/TIMP-1 ratio was correlated inversely with distensibility (rZK0.74, PZ
0.002) and to compliance (rZK0.58, PZ0.024) of the suprarenal aorta.
Conclusions. The CCA diameter was larger in AAA patients compared to AOD patients. MMP-9/TIMP-1 ratio was
associated with decreased distensibility and compliance of the suprarenal aorta. These data support the idea that AAA
patients exhibit a systemic dilation diathesis, which might be attributable to MMP/TIMP imbalances.Keywords: Abdominal aortic aneurysm; Aneurysm; Biomechanics; Etiology; Matrix metalloproteinase; Ultrasound;
Vascular remodelling.Introduction
Abdominal aortic aneurysm (AAA) is a relatively
common condition,1 characterised by degeneration
and dilational remodelling of the aortic wall.2 Matrix
metalloproteinases (MMPs) play an important role in
the remodelling process by degrading extracellular
matrix proteins such as elastin and collagen,3 both of
which are needed to maintain structural integrity and
favourable mechanical properties.4 In healthy tissue,
MMP activity is tightly regulated by tissue inhibitors
of metalloproteinases (TIMPs).5 Imbalance of MMP/
TIMP homeostasis in aneurysmal tissue has beening author. G.W.H. Schurink, MD, PhD, Department of
ersity Hospital of Maastricht, P.O. Box 5800, 6202 AZ
he Netherlands.
: gwh.schurink@surgery.azm.nl
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number of MMPs that have been identified thus far,
MMP-2 has most strongly been associated with small
aneurysms, while MMP-9 has been linked to medium-
sized,11 large6 or ruptured12 aneurysms. Furthermore,
plasma concentrations of MMP-9 appear not only to be
associated with aneurysmal disease,13 but also with
size and expansion rate of AAAs.14 Intriguingly, recent
studies demonstrated a fall in MMP-9 plasma levels
after successful exclusion of the AAA.15,16
The altered MMP/TIMP homeostasis and matrix
protein content that characterise the aneurysmal wall
have also been found in non-aneurysmal segments of
the vasculature of AAA-patients.17,18 Similarly, modi-
fied vessel wall properties, such as reduced distensi-
bility, have been described not only for the aneurysm
itself, but also for the (non-affected) carotid artery of
patients with AAA.19–21 In addition, some authorsEur J Vasc Endovasc Surg 29, 371–377 (2005)
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L. W. van Laake et al.372observed structural dilation of non-affected arteries in
these patients.20–23 All together, these observations
suggest that the pathogenesis of abdominal aortic
aneurysms involves systemic factors that may affect
the entire vascular tree of the patient. In that case
alterations, similar to the changes in the aorta, could be
present in other, presumed healthy, arteries of patients
with AAA.
We hypothesised than an imbalance in plasma
MMP/TIMP level might be associated with a systemic
dilation diathesis as indicated by increased arterial
diameter and stiffness. Therefore, we studied mech-
anical vessel wall properties of non-affected arteries of
patients with either AAA or aorto-iliac occlusive
disease (AOD) and measured plasma MMP-9 and
TIMP-1.Materials and MethodsPatient selection
The study group consisted of 22 consecutive patients
with AAA and 12 with AOD, the latter group being
chosen as a control group because of the convincing
absence of a dilating diathesis in AOD patients as
compared to unselected age-matched subjects. Patient
characteristics of each group are listed in Table 1. AAA
patients were significantly older than AOD patients
(72.3 (G5.6) vs. 65.0 (G8.2) years, PZ0.005). The other
demographic details were similar for AAA and AOD
patients.
Exclusion criteria were a clinical history of active
infection, systemic inflammatory disease (e.g. rheu-
matoid arthritis, inflammatory bowel disease etc), oral
or parenteral corticosteroid therapy, significant co-
morbidity (i.e. malignancy) and symptomatic or
ruptured aneurysm. Furthermore, patients having
both aneurysmal and peripheral arterial occlusive
disease were excluded from the study.
Approval had been obtained from the Medical
Ethical Committee of University Hospital Maastricht
and all patients entered the study after giving written
informed consent.Ultrasonic assessment of aorta and carotid artery vascular
wall features
The common carotid artery (CCA) and suprarenal
aorta (SA) were chosen as sites of interest first because
they are accessible for non-invasive ultrasound
measurements and second because they are, just like
the infrarenal aorta and the iliac arteries, elasticEur J Vasc Endovasc Surg Vol 29, April 2005arteries (as opposed to muscular arteries such as the
femoral or brachial arteries).24
In order to assess arterial diameters and vessel wall
properties non-invasively, a modified ultrasound
system (Ultramark 9, ATL, Bellevue, WA, USA)
attached to a custom-built wall track system25 was
used. The CCA was examined with a 7.5-MHz linear
array scanner, whereas a 3.5-MHz curved array
scanner was used for the abdominal aorta. All
examinations were performed with the subjects in
supine position after 20 min of rest. A longitudinal
projection was used, the probe being placed at right
angles to the arterial wall. To reduce the chance of
observer bias, measurements of the CCA always were
performed before the aorta was visualised. Since,
diameter and vessel wall properties are usually equal
on both sides,24 only the right CCA was measured just
proximal to the carotid bulb in a plaque-free area. If
the presence of plaque was too extensive or a stenosis
was seen on the right side, measurements were
performed on the left CCA (3 AOD patients). In case
of bilateral stenosis (one AAA and three AOD patients,
PZ0.115, Fisher’s exact test), the least affected side
was used. Examination of the abdominal aorta was
performed at the suprarenal level just above the origin
of the most proximal renal artery. Due to the large
distance between the aorta and the probe or due to
bowel air blocking the transduction of ultrasound
signal, the suprarenal aorta could be assessed in only
11 AAA and four AOD patients.
During ultrasound examination the arterial blood
pressure was measured every 10 min with an auto-
matic oscillometric device (Dinamap, Critikon, Tampa,
Florida, USA), the cuff being placed around the upper
arm. This brachial artery blood pressure was used as a
substitute for the blood pressure in the CCA and aorta.
The end-diastolic diameter (d in mm) and diameter
change from diastole to systole (Dd in mm) of the CCA
and SA were determined as the median of five
measurements during five cardiac cycles at both
sites. The pulse pressure (Dp in kPa) was defined as
the difference between systolic and diastolic blood
pressure. Elastic properties were calculated according
to the following equations.26
Relative distensionZ
Dd
d
!100ð%Þ
Distensibility ðDCÞZ 2Dd=d
Dp
!103ðMPaK1Þ
Compliance ðCCÞZP!dDd
2Dp
ðmm2=kPaÞ
Table 1. Patient characteristics
AAA (nZ22) AOD (nZ12) P value
Age (y) 72.3G5.6 65.0G8.2 0.005*
Sex (male:female) 18:4 8:4 0.410
Aneurysm size (mm) 53G10 – –
Hypertension 18 (82) 9 (75) 0.677
Diabetes 2 (9) 5 (42) 0.070
Dyslipidaemia 15 (68) 10 (83) 0.439
Current smoking 14 (64) 7 (58) 7621.00
Packyears (y) 43.1G21.1 38.1G16.9 0.564
PAOD 0 (0) 12 (100) !0.001*
Coronary AD 11 (50) 6 (50) 1.00
Cerebral AD 5 (23) 2 (17) 0.672
Other AD 0 (0) 2 (17) 0.118
Family history of
AAA
3 (14) 0 (0) 0.537
Family history of
occlusive AD
10 (45) 6 (50) 0.800
Values are expressed as meanGSD or number (%). PAOD,
peripheral arterial occlusive disease, defined as a history of
claudication, critical limb ischemia and/or arterial leg ulceration in
combination with an ankle-brachial pressure index!0.9; AD,
arterial disease. Hypertension, diabetes, dyslipidaemia and ADs
(e.g. renal/subclavian artery stenosis), were defined as the condition
being confirmed by a physician and/or the patient receiving
medication or other interventions for the condition; AAA, abdomi-
nal aortic aneurysm patients; AOD, aorto-iliac occlusive disease
patients.
* Statistical significance at P-level!0.05.
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Peripheral venous blood samples were taken from
each patient directly after the ultrasound examination.
The blood was collected in EDTA tubes and centri-
fuged at 2423 rpm for 10 min within 1 h after collection
to obtain plasma, which was stored at K20 8C until
analysis.Plasma MMP-9 and TIMP-1 measurements
Commercially available enzyme-linked immunosor-
bent assay (ELISA) kits (Biotrak Human ELISA
System, Amersham Life Science, Buckinghamshire,
UK) were used according to the manufacturer’s
instructions to measure plasma concentrations of
MMP-9 and TIMP-1 in 19 AAA and 12 AOD patients.
Blood samples of three patients in the AAA group
were not suitable for analysis due to technical
problems during storage. All samples were run in
duplicate.
The MMP-9 assay recognises free pro-MMP-9 and
the pro-MMP-9/TIMP-1 complex. Its intra- and inter-
assay variabilities are !5.5 and !9.8%, respectively.
The TIMP-1 assay recognises all forms of TIMP-1 with
an intra-assay variability of!11.4% and an inter-assay
variability of !15.2%. None of the assays show
significant cross-reactivity with other than the targetMMP or TIMP (reproducibility and cross-reactivity
analyses by manufacturer).Statistical analysis
SPSS 10.0 for Windows was used for the statistics.
Differences in means of continuous variables between
AAA and AOD were assessed with the 1-way ANOVA
or Mann–Whitney U test, as appropriate. Univariate
analyses of variance were performed to correct for age
differences and sex. Comparison of cardiovascular risk
factors between the AAA and AOD groups was
performed with Fisher’s exact test. Correlations of
MMP and MMP/TIMP ratio plasma levels and
ultrasound parameters were tested with Spearman’s
correlation coefficient.ResultsUltrasonographyCommon carotid artery
The CCA was measured in all 34 patients. Blood
pressure, diameter, (relative) distension, distensibility
and compliance are shown in Table 2.
The CCA diameter correlated significantly with age
(rZ0.38, PZ0.025). Mean CCA diameter (GSD) was
9.1 (G1.3) vs. 7.8 (G1.4) mm in the AAA and AOD
group, respectively. This difference was highly signifi-
cant (PZ0.009) and persisted after correction for age
and sex (PZ0.022), Table 3.
The relative distension and distensibility of the
CCA decreased with age (rZK.37, PZ0.03 and
rZK0.52, PZ0.002, respectively). CCA distensibility
was not significantly different between AAA and AOD
patients (PZ0.26). CCA compliance showed no
correlation with age and did not differ between AAA
and AOD patients.Suprarenal aorta
Due to technical problems (intestinal air, depth of
aorta), the SA was measured in 15 patients (11 AAA
and four AOD patients) only. Data on blood pressure,
diameter, (relative) distension, distensibility, compli-
ance, age, sex, and body size are shown in Table 4.
Diameter, (relative) distension, and compliance did
not correlate with age. Furthermore, none of these
parameters differed between the two patient groups at
the level of the suprarenal aorta.Eur J Vasc Endovasc Surg Vol 29, April 2005
Table 2. Biomechanical properties at the level of the common
carotid artery
AAA nZ22 AOD nZ12 P value
Height (m) 1.71G0.07 1.69G0.08 0.471
Weight (kg) 80.0G15.3 75.9G18.9 0.207
BMI (kg/m2) 27.4G4.3 26.6G6.4 0.349
BSA (m2) 1.91G0.20 1.85G0.22 0.349
Systolic BP (mmHg) 146G16 149G22 0.387
Diastolic BP (mmHg) 80G9 78G11 0.613
Pulse pressure (kPa) 8.8G1.6 9.5G2.7 0.121
Diameter (mm) 9.1G1.3 7.8G1.4 0.009*
Distension (mm) 0.40G0.16 0.41G0.16 0.614
Relative distension
(%)
4.4G1.8 5.5G2.2 0.135
Distensibility
(1/MPa)
10.5G4.5 12.4G6.3 0.264
Compliance
(mm2/kPa)
0.68G0.28 0.55G0.22 0.171
Values are expressed as meanGSD. BMI, body mass index; BSA,
body surface area; BMI, weight (kg)/height (m)2; BSA, weight
(kg)0.425!height (cm)0.725!71.84 (du Bois’ formula); BP, blood
pressure; CCA, common carotid artery; kPa, kilo-Pascal; Mpa, mega-
Pascal; AAA, abdominal aortic aneurysm patients; AOD, aorto-iliac
occlusive disease patients.
* Statistical significance at P-level!.05.
L. W. van Laake et al.374Plasma MMP-9 and TIMP-1 concentrations
Plasma concentrations of MMP-9 and TIMP-1 (Table 5)
were similar for AAA and AOD patients. Further-
more, the MMP-9/TIMP-1 ratio, indicating the poten-
tial activity of MMP-9, did not differ between AAA
and AOD patients (Table 5).Correlations between MMP-9 and TIMP-1 plasma levels
and vessel wall characteristics
Since, no differences were found in MMP and TIMP
levels between AAA and AOD patients, the patients
were pooled together in order to study the relation
between MMP-9/TIMP-1 and vessel wall biomecha-
nics. No correlation was observed between MMP-9
concentration, TIMP-1 concentration or MMP-
9/TIMP-1 ratio and diameter or mechanical properties
of the CCA. However, as shown in Fig. 1, the MMP-9/
TIMP-1 ratio was inversely related to the relative
distension of the SA (rZK0.66, PZ0.007, nZ15), to SA
distensibility (rZK0.74, PZ0.002, nZ15) and to SA
compliance (rZK0.58, PZ0.024, nZ15).Table 3. CCA diameter uncorrected and corrected for age and sex wi
CCA diameter (mm)
Estimated CCA diameter (mm) (corrected for sex and age)
Values are expressed as mean (95% confidence interval). CCA, commo
aorto-iliac occlusive disease patients.
* Statistically significant (P!0.05)for the comparison of (estimated) C
Eur J Vasc Endovasc Surg Vol 29, April 2005Discussion
In the present study, we have shown that the common
carotid artery was larger in patients with AAA
compared to those with AOD. Furthermore, the
MMP-9/TIMP-1 ratio was inversely related to relative
distension, distensibility, and compliance of the
suprarenal aorta. These data support the concept that
patients with AAA suffer from a generalised condition
rather than a local disease. MMP-9 activity may play a
role in the systemic dilating process.
Elastic arteries, such as the carotid artery27–29 and
the aorta30,31 become stiffer with increasing age.
Indeed, we found an inverse correlation between age
and distensibility of the common carotid artery.
Furthermore, arterial stiffness is associated with vessel
diameter. As vascular elasticity decreases, the diastolic
diameter increases in an attempt to keep vascular
compliance, the volume buffering capacity, constant
without a rise in pulse pressure.32 This is consistent
with our observation of a positive correlation between
age and diameter of the CCA. Considering these age-
dependent changes of vascular properties, a small
difference in CCA diameter between AAA and AOD
patients would not be surprising, given the age-
difference between these patient groups. However,
the 1.3 mm increase in CCA diameter of patients with
AAA compared to those with AOD remained highly
significant after correction for age and sex. Further-
more, both the absolute and relative difference
between the measured and the predicted CCA
diameter (based on age and sex using the formula
proposed by Samijo et al.29) were significantly larger
for AAA patients compared to AOD patients.
To reduce the chance that the presence of athero-
sclerotic plaques distorted our results, we performed
our measurements in a plaque-free area. In cases with
bilateral carotid plaques (nZ4), the less affected site
was chosen for measurements. An additional analysis
was done after exclusion of these cases, showing again
that CCA diameter was significantly larger in patients
with aneurysmal disease (data not shown). These data
are in accordance with the observations of Tilson and
Dang, Ward, Makita et al., and Boutouyrie et al.20–23
Nevertheless, Sandgren et al. found no increase in
arterial dimensions in the common femoral andth analysis of variance
AAA (nZ22) AOD (nZ12) P value
9.1 (8.6–9.7) 7.8 (7.1–8.6) 0.009*
9.1 (8.5–9.7) 7.9 (7.1–8.7) 0.022*
n carotid artery; AAA, abdominal aortic aneurysm patients; AOD,
CA diameter between AAA- and AOD-patients.
Table 4. Biomechanical properties at the level of the suprarenal
aorta
AAA nZ11 AOD nZ4 P value
Age (y) 72.6G4.2 70.2G10.5 0.896
Sex (male:female) 8:3 2:2 0.560
Height (m) 1.69G0.07 1.67G0.09 0.556
Weight (kg) 70.4G12.8 62.8G10.9 0.151
BMI (kg/m2) 24.4G3.5 22.5G2.1 0.192
BSA (m2) 1.80G0.19 1.70G0.19 0.192
Systolic BP (mmHg) 154G13 155G20 0.896
Diastolic BP (mmHg) 82G10 75G19 0.472
Pulse pressure (kPa) 9.7G1.2 10.6G1.7 0.360
Diameter (mm) 21.1G4.8 21.7G5.1 0.794
Distension (mm) 0.58G0.43 0.46G0.12 1.00
Relative distension
(%)
2.7G1.6 2.3G0.9 0.794
Distensibility
(1/MPa)
5.6G3.3 4.5G2.4 0.647
Compliance
(mm2/kPa)
2.0G1.8 1.5G0.6 1.00
Values are expressed as meanGSD. BMI, body mass index; BSA,
body surface area; BMI, weight (kg)/height (m)2; BSA, weight
(kg)0.425!height (cm)0.725!71.84 (du Bois’ formula); kPa, kilo-
Pascal; Mpa, mega-Pascal; AAA, abdominal aortic aneurysm
patients; AOD, aorto-iliac occlusive disease patients.
Fig. 1. (a) MMP-9/TIMP-1 ratio vs. SA relative distension. (b)
MMP-9/TIMP-1 ratio vs. SA distensibility. MMP-9/TIMP-1
ratio vs. SA compliance.
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discrepancy may result from different biomechanical
and structural properties of muscular compared to
elastic arteries such as the carotid artery. However, we
found no difference in diameter of the suprarenal aorta
in AAA vs. AOD patients. This might be attributable to
the small number of observations.
Dilation of a non-affected artery, such as the CCA, in
patients with AAA supports the idea that AAA is a
systemic disease with local manifestations in the parts
of the arterial tree most sensitive to aneurysmal
degeneration. This concept is further supported by
observations of increased MMP activity,17 increased
collagen/elastin ratio18 and reduced distensibility19–21
in non-aneurysmal arterial segments of AAA patients.
In contrast to the latter observation, the distensibility
at the level of the common carotid artery and the
suprarenal aorta was not significantly decreased in
AAA compared to AOD patients in our study,
although only four AOD patients were included.
This is in contrast to studies comparing AAA patients
and healthy control subjects used Sonesson et al.19 andTable 5. PlasmaMMP-9 and TIMP-1 concentration in patients with
AAA and AOD
AAA nZ19 AOD nZ12 P value
MMP-9 (ng/ml) 61G49 51G28 0.887
TIMP-1 (ng/ml) 1064G210 1033G328 0.394
MMP-9/TIMP-1 0.063G0.057 0.054G0.039 0.935
Values are expressed as meanGSD. AAA, abdominal aortic
aneurysm patients; AOD, aorto-iliac occlusive disease patients;
MMP-9, matrix metalloproteinase-9; TIMP-1, tissue inhibitor of
metalloproteinases-1.Boutouyrie et al.20 or to the study with perfect age
matching of the AAA and atherosclerotic control
group by Makita et al.21 The age difference of our
patient-groups may be a critical issue. Non-invasively
measured brachial blood pressure has been used as
substitute for aortic and carotid arterial blood press-
ure, which could overestimate pressure in the aorta
and carotid artery because of augmentation of press-
ure waves peaks by wave reflection from the periph-
ery (arterial bifurcations). The difference betweenEur J Vasc Endovasc Surg Vol 29, April 2005
L. W. van Laake et al.376peripheral and central blood pressures decreases with
age.34 Therefore, in our population with a mean age of
70.3 years, this approximation seemed reasonable.
However, since AOD patients were significantly
younger than AAA patients, we might assume that
the possible overestimation of central pulse pressure
would be more pronounced in the AOD group,
leading to a stronger underestimation of distensibility
in these patients. The relatively stronger underestima-
tion of distensibility in the AOD group may be
responsible for the lack of significant difference in
distensibility between AAA and AOD patients in our
analysis.
MMPs have been shown to be of major importance
in the pathogenesis of AAAs.35–37 However, in contrast
to others13,38 we did not find a difference in MMP and
TIMP concentrations or MMP/TIMP ratios when
comparing plasma of AAA with that of AOD patients.
In agreement with our observation, a recent study
reported increased MMP-9 gene expression in both
atherosclerotic and aneurysmal aortic tissue.39 Both
atherosclerotic plaque and aneurysm formation are
characterized by extensive remodelling. MMPs seem
to play a key role in both inward and outward
remodelling associated with atherosclerosis and
aneurysm formation, respectively.40 Intriguingly, the
same molecular process (MMP-9 activation) leads to
different outcomes in patients with aneurysmal vs.
obstructive disease. The interaction of MMP-9 with
genetic and environmental factors may determine the
direction of the remodelling process, i.e. outward vs.
inward. The familial occurrence of both aneurysmal
and arterial occlusive disease indicates that a genetic
basis is likely, although as yet uncharacterised.
Anatomical, hemodynamical, and immunogenic vari-
ables are all dependent on a combination of hereditary
and environmental (smoking, food, etc) factors.
Together such factors (mediated by molecules secreted
by the vessel wall or inflammatory cells) may play a
key role in directing inward or outward vascular
remodelling.
It is questionable whether plasma MMP-9 concen-
trations are directly proportional to aortic MMP-9
production and activity. To our knowledge, only
Hovsepian et al. reported an exponential relationship
between MMP-9 production in aneurysmal tissue and
plasma MMP-9 concentration, based on measurement
in four patients.38 Nevertheless, tissue MMP-9 activity
and plasma MMP-9 levels are associated with aneur-
ysm-size,11,14 and even more interestingly, plasma
MMP-9 levels decrease upon successful aneurysm
exclusion,15 suggesting that plasma levels of MMP-9
may reflect MMP-9 activity in diseased aortic tissue.
Further studies are needed to assess the relationEur J Vasc Endovasc Surg Vol 29, April 2005between plasma MMP concentration and tissue
MMP production and activity.
To explore the putative role of MMP/TIMP imbal-
ance as a systemic AAA-promoting factor, we ana-
lyzed the association between MMP/TIMP plasma
levels and vessel wall characteristics, indicative of
early aneurysmal changes, in healthy arterial seg-
ments of patients with AAA or AOD. Interestingly, an
increased MMP-9/TIMP-1 ratio was related to a
decreased suprarenal aortic distensibility and compli-
ance. Since, the MMP-9/TIMP-1 ratio may reflect the
MMP-9 activity potential, our data suggest that
increased MMP-9 activity is related to increased
stiffness of the suprarenal aortic wall, probably
through degradation of extracellular matrix proteins
such as elastin and collagen,3,5 the main determinants
of large artery wall mechanics. We have demonstrated
merely a correlation between MMP-9 activity and
suprarenal aortic stiffness, and not a causal relation.
Stiffening of the vascular wall may actually precede
activation of MMP-9. In such a case, MMP-9 would be
produced in order to stimulate outward remodelling
to keep compliance at the desired level. Either way, the
remodelling process will be less or more active at
different sites of the arterial tree, depending on the
need to compensate for increased stiffness of the
vascular wall. Once compensating outward remodel-
ling has been completed, plasma MMP-9 level may no
longer be related to biomechanical vessel wall proper-
ties. This may explain why in our study the distensi-
bility and compliance of the wide (outwardly
remodelled) common carotid artery was unrelated to
plasma MMP-9 concentration.
In conclusion, this study supports the idea that
AAA patients exhibit a systemic dilation diathesis,
indicated by an increased diameter of the common
carotid artery. Given the association between a
systemic biochemical marker (plasma MMP-9) and
biomechanical vessel wall properties presented here,
this dilation diathesis may be attributable to an
MMP/TIMP imbalance.References
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